NEW YORK(GenomeWeb) – Genomic mapping firm BioNano Genomics today announced it completed a Series C financing round that raised $53 million.
The funds will be used to increase the installed base of the company's Irys platform and to develop next-generation platforms and technologies. Legend Capital and Novartis Venture Fund co-led the round. New investors in the round included Federated Kaufmann Fund and Monashee Investment Management. Existing investors Domain Associates, Battelle Ventures, and Gund Investment also participated in the round.